{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:19:43Z","timestamp":1793974783499,"version":"4.8.0"},"reference-count":113,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Cancer Research Funds of Radiumhemmet","award":["Annika Bergquist"],"award-info":[{"award-number":["Annika Bergquist"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["egastro"],"accepted":{"date-parts":[[2024,1,3]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease, characterised by persistent biliary inflammation resulting in fibrosis and multifocal strictures of the biliary tree. The course of disease is highly variable, ranging from asymptomatic disease to the development of end-stage biliary cirrhosis and an increased risk of biliary tract cancer (BTC), particularly cholangiocarcinoma (CCA).<\/jats:p>\n               <jats:p>PSC is the most important risk factor for CCA in younger people, with a reported lifetime prevalence ranging from 6% to 13%. Perihilar CCA (pCCA), involving the hepatic duct bifurcation, is the most common CCA amounting to approximately 50% of all cases, whereas intrahepatic CCA (iCCA), located within the hepatic parenchyma, represents less than 10%.<\/jats:p>\n               <jats:p>CCA is an aggressive tumour, and only a minority of patients are amenable to surgical resection with curative intent. Radical liver resection and liver transplantation are potentially curative therapeutic options in patients with PSC in the absence of metastatic or locally advanced disease. Liver transplantation with neoadjuvant chemoradiation could be considered in selected patients with unresectable pCCA and without pretreatment in patients with PSC with bile duct high-grade dysplasia. Recent reports demonstrating favourable outcomes in transplanted patients with small iCCA and patients with locally advanced disease following neoadjuvant therapy have challenged the previously described poor outcome in transplanted patients with iCCA.<\/jats:p>\n               <jats:p>Treatment for CCA is challenged by the inherent difficulties in enabling an early diagnosis and thereby preventing an otherwise dismal prognosis. This comprehensive review aims to describe therapeutic considerations and challenges in patients with PSC-CCA.<\/jats:p>","DOI":"10.1136\/egastro-2023-100045","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T13:05:17Z","timestamp":1711717517000},"page":"e100045","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review"],"prefix":"10.1136","volume":"2","clinical-trial-number":[{"clinical-trial-number":"nct02232932","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02878473","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04195503","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4696-0931","authenticated-orcid":false,"given":"Christina","family":"Villard","sequence":"first","affiliation":[{"name":"Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden"},{"name":"Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Jorns","sequence":"additional","affiliation":[{"name":"Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Clinical Science Intervention and Technology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[{"name":"Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden"},{"name":"Division of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"2025081719113376000_2.1.e100045.1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(66)90339-4"},{"key":"2025081719113376000_2.1.e100045.2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528009181516"},{"key":"2025081719113376000_2.1.e100045.3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"key":"2025081719113376000_2.1.e100045.4","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","article-title":"Natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies","volume":"20","author":"Trivedi","year":"2022","journal-title":"Clin Gastroenterol Hepato"},{"key":"2025081719113376000_2.1.e100045.5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26565"},{"key":"2025081719113376000_2.1.e100045.6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29204"},{"key":"2025081719113376000_2.1.e100045.7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/2050640617717156","article-title":"Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis","volume":"6","author":"Rupp","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"2025081719113376000_2.1.e100045.8","doi-asserted-by":"publisher","DOI":"10.5009\/gnl16510"},{"key":"2025081719113376000_2.1.e100045.9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.02.038"},{"key":"2025081719113376000_2.1.e100045.10","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22131"},{"key":"2025081719113376000_2.1.e100045.11","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3181c9dac6"},{"key":"2025081719113376000_2.1.e100045.12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27074"},{"key":"2025081719113376000_2.1.e100045.13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"2025081719113376000_2.1.e100045.14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007116","article-title":"Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2025081719113376000_2.1.e100045.15","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10214-6"},{"key":"2025081719113376000_2.1.e100045.16","doi-asserted-by":"publisher","DOI":"10.1080\/003655202760373434"},{"key":"2025081719113376000_2.1.e100045.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00288-4"},{"key":"2025081719113376000_2.1.e100045.18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2022.11.011","article-title":"Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis","volume":"78","author":"Villard","year":"2023","journal-title":"J Hepatol"},{"key":"2025081719113376000_2.1.e100045.19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jgh3.12405","article-title":"The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival","volume":"4","author":"Chahal","year":"2020","journal-title":"JGH Open"},{"key":"2025081719113376000_2.1.e100045.20","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13516"},{"key":"2025081719113376000_2.1.e100045.21","doi-asserted-by":"publisher","DOI":"10.1038\/ng.728"},{"key":"2025081719113376000_2.1.e100045.22","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3745"},{"key":"2025081719113376000_2.1.e100045.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.03.031"},{"key":"2025081719113376000_2.1.e100045.24","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13979"},{"key":"2025081719113376000_2.1.e100045.25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312180"},{"key":"2025081719113376000_2.1.e100045.26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.058"},{"key":"2025081719113376000_2.1.e100045.27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2001.00775.x"},{"key":"2025081719113376000_2.1.e100045.28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI73742"},{"key":"2025081719113376000_2.1.e100045.29","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181bc96f9"},{"key":"2025081719113376000_2.1.e100045.30","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.28529","article-title":"Aspirin use and the risk of cholangiocarcinoma","volume":"64","author":"Choi","year":"2016","journal-title":"Hepatology"},{"key":"2025081719113376000_2.1.e100045.31","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000251366.62632.d3"},{"key":"2025081719113376000_2.1.e100045.32","doi-asserted-by":"publisher","DOI":"10.1177\/028418519203300413"},{"key":"2025081719113376000_2.1.e100045.33","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3375"},{"key":"2025081719113376000_2.1.e100045.34","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yexmp.2015.07.005","article-title":"Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing","volume":"99","author":"Putra","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"2025081719113376000_2.1.e100045.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.008"},{"key":"2025081719113376000_2.1.e100045.36","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.01.001"},{"key":"2025081719113376000_2.1.e100045.37","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213435.99492.8a"},{"key":"2025081719113376000_2.1.e100045.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.02.008"},{"key":"2025081719113376000_2.1.e100045.39","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.cgh.2018.04.047","article-title":"Characteristics and outcomes reported by patients with primary sclerosing cholangitis through an online registry","volume":"17","author":"Kuo","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025081719113376000_2.1.e100045.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.01.025"},{"key":"2025081719113376000_2.1.e100045.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.12.010"},{"key":"2025081719113376000_2.1.e100045.42","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.29293","article-title":"Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the international PSC study group","volume":"66","author":"Schramm","year":"2017","journal-title":"Hepatology"},{"key":"2025081719113376000_2.1.e100045.43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J Hepatol"},{"key":"2025081719113376000_2.1.e100045.44","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283554bbf"},{"key":"2025081719113376000_2.1.e100045.45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04106.x"},{"key":"2025081719113376000_2.1.e100045.46","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-003-1175-y"},{"key":"2025081719113376000_2.1.e100045.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.05.017"},{"key":"2025081719113376000_2.1.e100045.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.05.002"},{"key":"2025081719113376000_2.1.e100045.49","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"key":"2025081719113376000_2.1.e100045.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30281.x"},{"key":"2025081719113376000_2.1.e100045.51","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1478-3231.2011.02672.x","article-title":"Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity","volume":"32","author":"Halme","year":"2012","journal-title":"Liver Int"},{"key":"2025081719113376000_2.1.e100045.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2013.11.001"},{"key":"2025081719113376000_2.1.e100045.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2010.08.050"},{"key":"2025081719113376000_2.1.e100045.54","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for 'very early' intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"2025081719113376000_2.1.e100045.55","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22441"},{"key":"2025081719113376000_2.1.e100045.56","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24570"},{"key":"2025081719113376000_2.1.e100045.57","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-2927-8"},{"key":"2025081719113376000_2.1.e100045.58","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80198-6"},{"key":"2025081719113376000_2.1.e100045.59","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15146"},{"key":"2025081719113376000_2.1.e100045.60","doi-asserted-by":"crossref","first-page":"29271","DOI":"10.1016\/S0021-9258(19)62041-7","article-title":"Molecular genetic analysis of the human Lewis histo-blood group system","volume":"269","author":"Nishihara","year":"1994","journal-title":"J Biol Chem"},{"key":"2025081719113376000_2.1.e100045.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.08.005"},{"key":"2025081719113376000_2.1.e100045.62","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","article-title":"AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"17","author":"Bowlus","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025081719113376000_2.1.e100045.63","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29730"},{"key":"2025081719113376000_2.1.e100045.64","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1076681"},{"key":"2025081719113376000_2.1.e100045.65","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/SLA.0000000000004322","article-title":"Combined vascular resection for locally advanced perihilar cholangiocarcinoma","volume":"275","author":"Mizuno","year":"2022","journal-title":"Ann Surg"},{"key":"2025081719113376000_2.1.e100045.66","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.hpb.2021.04.011","article-title":"Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study","volume":"23","author":"Jansson","year":"2021","journal-title":"HPB (Oxford)"},{"key":"2025081719113376000_2.1.e100045.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2017.08.011"},{"key":"2025081719113376000_2.1.e100045.68","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jamcollsurg.2015.09.005","article-title":"Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection","volume":"221","author":"Groot Koerkamp","year":"2015","journal-title":"J Am Coll Surg"},{"key":"2025081719113376000_2.1.e100045.69","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30915-X"},{"key":"2025081719113376000_2.1.e100045.70","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02178"},{"key":"2025081719113376000_2.1.e100045.71","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease","volume":"267","author":"Ethun","year":"2018","journal-title":"Ann Surg"},{"key":"2025081719113376000_2.1.e100045.72","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.12.030"},{"key":"2025081719113376000_2.1.e100045.73","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ejso.2023.01.006","article-title":"Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"49","author":"Jansson","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"2025081719113376000_2.1.e100045.74","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/bjs.10921","article-title":"Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma","volume":"105","author":"Bird","year":"2018","journal-title":"Br J Surg"},{"key":"2025081719113376000_2.1.e100045.75","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"key":"2025081719113376000_2.1.e100045.76","first-page":"1","article-title":"Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation","volume":"74","author":"Stieber","year":"1989","journal-title":"Int Surg"},{"key":"2025081719113376000_2.1.e100045.77","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200004270-00019"},{"key":"2025081719113376000_2.1.e100045.78","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-828896"},{"key":"2025081719113376000_2.1.e100045.79","doi-asserted-by":"publisher","DOI":"10.1053\/lv.2000.6143"},{"key":"2025081719113376000_2.1.e100045.80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jamcollsurg.2012.03.014","article-title":"Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary","volume":"215","author":"Rosen","year":"2012","journal-title":"J Am Coll Surg"},{"key":"2025081719113376000_2.1.e100045.81","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.008"},{"key":"2025081719113376000_2.1.e100045.82","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1097\/SLA.0000000000005190","article-title":"Meta-analysis and meta-regression of survival after liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"274","author":"Cambridge","year":"2021","journal-title":"Ann Surg"},{"key":"2025081719113376000_2.1.e100045.83","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1245\/s10434-020-08682-5","article-title":"Center experience affects liver transplant outcomes in patients with hilar cholangiocarcinoma","volume":"27","author":"Kitajima","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2025081719113376000_2.1.e100045.84","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113157","article-title":"Selected patients with unresectable perihilar cholangiocarcinoma (pCCA) derive long-term benefit from liver transplantation","volume":"12","author":"Azad","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2025081719113376000_2.1.e100045.85","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jamcollsurg.2019.12.037","article-title":"Living donor liver transplantation for perihilar cholangiocarcinoma: outcomes and complications","volume":"231","author":"Tan","year":"2020","journal-title":"J Am Coll Surg"},{"key":"2025081719113376000_2.1.e100045.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.07.005"},{"key":"2025081719113376000_2.1.e100045.87","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/tri.13925","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European liver transplant registry and beyond","volume":"34","author":"Visseren","year":"2021","journal-title":"Transpl Int"},{"key":"2025081719113376000_2.1.e100045.88","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cld.2023.07.009","article-title":"Post-transplant management and complications of autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis including disease recurrence","volume":"28","author":"Henson","year":"2024","journal-title":"Clin Liver Dis"},{"key":"2025081719113376000_2.1.e100045.89","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.327"},{"key":"2025081719113376000_2.1.e100045.90","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jamcollsurg.2012.05.025","article-title":"The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients","volume":"215","author":"Matsuo","year":"2012","journal-title":"J Am Coll Surg"},{"key":"2025081719113376000_2.1.e100045.91","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0022"},{"issue":"Suppl 3","key":"2025081719113376000_2.1.e100045.92","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1245\/s10434-020-09001-8","article-title":"Eligibility for liver transplantation in patients with perihilar cholangiocarcinoma","volume":"28","author":"Vugts","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2025081719113376000_2.1.e100045.93","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.51"},{"key":"2025081719113376000_2.1.e100045.94","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.1219"},{"key":"2025081719113376000_2.1.e100045.95","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00027-9"},{"key":"2025081719113376000_2.1.e100045.96","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0191"},{"key":"2025081719113376000_2.1.e100045.97","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00727-4"},{"key":"2025081719113376000_2.1.e100045.98","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jamaoncol.2021.3836","article-title":"Final overall survival efficacy results of ivosidenib for patients with advanced cholangiocarcinoma with IDH1 Mutation: the phase 3 randomized clinical ClarIDHy trial","volume":"7","author":"Zhu","year":"2021","journal-title":"JAMA Oncol"},{"key":"2025081719113376000_2.1.e100045.99","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/jso.24759","article-title":"Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma","volume":"116","author":"Buettner","year":"2017","journal-title":"J Surg Oncol"},{"key":"2025081719113376000_2.1.e100045.100","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.6519"},{"key":"2025081719113376000_2.1.e100045.101","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1245\/s10434-019-08192-z","article-title":"ALPPS for locally advanced intrahepatic cholangiocarcinoma: did aggressive surgery lead to the oncological benefit? An international multi-center study","volume":"27","author":"Li","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2025081719113376000_2.1.e100045.102","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1007\/s00464-016-4817-x","article-title":"Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma","volume":"30","author":"Lee","year":"2016","journal-title":"Surg Endosc"},{"key":"2025081719113376000_2.1.e100045.103","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/bjs.10676","article-title":"Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent","volume":"105","author":"Zhang","year":"2018","journal-title":"Br J Surg"},{"key":"2025081719113376000_2.1.e100045.104","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jso.24524","article-title":"The effect of preoperative chemotherapy treatment in surgically treated Intrahepatic cholangiocarcinoma patients-A multi-institutional analysis","volume":"115","author":"Buettner","year":"2017","journal-title":"J Surg Oncol"},{"key":"2025081719113376000_2.1.e100045.105","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2001.29419"},{"key":"2025081719113376000_2.1.e100045.106","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/lt.25737","article-title":"Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis","volume":"26","author":"De Martin","year":"2020","journal-title":"Liver Transpl"},{"key":"2025081719113376000_2.1.e100045.107","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025081719113376000_2.1.e100045.108","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jso.23605","article-title":"Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis","volume":"110","author":"Amini","year":"2014","journal-title":"J Surg Oncol"},{"key":"2025081719113376000_2.1.e100045.109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102258","article-title":"Locoregional therapies in patients with Intrahepatic cholangiocarcinoma: a systematic review and pooled analysis","volume":"99","author":"Edeline","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"2025081719113376000_2.1.e100045.110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00270-021-02800-w","article-title":"Transarterial chemoembolization and radioembolization for unresectable intrahepatic cholangiocarcinoma-a systemic review and meta-analysis","volume":"44","author":"Mosconi","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2025081719113376000_2.1.e100045.111","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1080\/0284186X.2019.1590634","article-title":"Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study","volume":"58","author":"Strijker","year":"2019","journal-title":"Acta Oncol"},{"key":"2025081719113376000_2.1.e100045.112","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1007\/s00268-010-0624-z","article-title":"Pancreaticoduodenectomy after liver transplantation in patients with primary sclerosing cholangitis complicated by distal pancreatobiliary malignancy","volume":"34","author":"Sutcliffe","year":"2010","journal-title":"World J Surg"},{"key":"2025081719113376000_2.1.e100045.113","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ueg2.12204","article-title":"Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: a population-based cohort study","volume":"10","author":"Yu","year":"2022","journal-title":"United European Gastroenterol J"}],"container-title":["eGastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/egastro-2023-100045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T02:16:05Z","timestamp":1755483365000},"score":1,"resource":{"primary":{"URL":"http:\/\/egastroenterology.bmj.com\/lookup\/doi\/10.1136\/egastro-2023-100045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3,29]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/egastro-2023-100045"],"URL":"https:\/\/doi.org\/10.1136\/egastro-2023-100045","relation":{},"ISSN":["2766-0125","2976-7296"],"issn-type":[{"value":"2766-0125","type":"print"},{"value":"2976-7296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}